Results 91 to 100 of about 10,088 (191)
Improving solubility and storage stability of rifaximin: Via solid-state solvation with Transcutol®
Crystallization of rifaximin from 2-(2-ethoxyethoxy)ethanol (Transcutol®, DEGME or DEGEE), an inactive ingredient approved by the FDA and a solvent commonly used in the pharmaceutical and cosmetic fields, affords a crystalline form of the API with better
Sforzini A. +6 more
core +1 more source
Background & Aims: Rifaximin-alpha reduces the risk of recurrence of overt hepatic encephalopathy. However, there remain concerns regarding the financial cost of the drug.
Shawcross D +16 more
core +3 more sources
Background: Diarrhea-predominant irritable bowel syndrome (IBS-D) impairs patient quality of life (QOL). Rifaximin is an oral, nonsystemic antibiotic indicated for IBS-D.
Brooks D. Cash +6 more
doaj +1 more source
Rifaximin for the treatment of acute infectious diarrhea
Rifaximin is a nonabsorbable rifamycin derivative with an excellent safety profile and a broad spectrum of antimicrobial activity against a variety of enteropathogens causing acute infectious diarrhea.
Joo Sung Kim, Kyoung Sup Hong
core +1 more source
Metabolic dysfunction-associated steatohepatitis (MASH) has become a serious public health problem, posing an increasingly dangerous threat to human health owing to its increasing prevalence and accompanying intra- and extrahepatic adverse outcomes ...
Ting Qiu +5 more
doaj +1 more source
Crystal forms of rifaximin and their effect on pharmaceutical properties
Five distinct crystal forms of rifaximin have been identified and characterised by X-ray powder diffraction, solid state 13C NMR, and HATR-IR spectroscopy.
M. Campana +9 more
core +1 more source
Efficacy and Safety of Short-term Administration of Rifaximin in the Treatment of Hepatic Encephalopathy [PDF]
Background/Aims: A prospective, randomized study was performed to evaluate the efficacy and safety of the short-term administration of rifaximin in the treatment of hepatic encephalopathy.
이관식, 백용한
core
Background Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that affects the prognosis of patients with liver disease and is considered an independent risk factor for hospitalization and death. Rifaximin has been approved for HE treatment. This
Guihua Fang, Shuna Liu, Bin Liu
doaj +1 more source

